BRK.B vs MRNA · rev $371.44B vs rev $145.0M
BRK.B (BRK.B) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
BRK.B currently screens at market cap $0. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the BRK.B and MRNA stock pages for the full models.
Not investment advice.